Advertisement
U.S. markets open in 11 minutes
  • S&P Futures

    5,308.00
    -0.25 (-0.00%)
     
  • Dow Futures

    40,176.00
    +32.00 (+0.08%)
     
  • Nasdaq Futures

    18,499.75
    -4.00 (-0.02%)
     
  • Russell 2000 Futures

    2,141.40
    +3.00 (+0.14%)
     
  • Crude Oil

    82.57
    +1.22 (+1.50%)
     
  • Gold

    2,233.10
    +20.40 (+0.92%)
     
  • Silver

    24.76
    +0.01 (+0.05%)
     
  • EUR/USD

    1.0812
    -0.0018 (-0.16%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • Vix

    12.96
    +0.18 (+1.41%)
     
  • GBP/USD

    1.2636
    -0.0002 (-0.02%)
     
  • USD/JPY

    151.3280
    +0.0820 (+0.05%)
     
  • Bitcoin USD

    70,570.68
    -659.02 (-0.93%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,955.83
    +23.85 (+0.30%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Analyzing The Price Action In Universe Pharmaceuticals Stock Today

Analyzing The Price Action In Universe Pharmaceuticals Stock Today The Price And Volume Action In Universe Pharmaceuticals's Stock Today

Universe Pharmaceuticals (NASDAQ:UPC) is currently up 65.66% to a price of $7.02. Monday the stock has been traded at a volume of 34.88 million, about 5641.43% of its recent 30-day volume average of 618.34 thousand.

Why It's Moving

Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Universe Pharmaceuticals shares are trading higher amid continued post-IPO volatility.

Further Analysis of Recent Price Action

The stock's 50-day moving average was $4.26 at the time this article was published. Over the past fifty-two weeks, the price has risen as high as $5.72 and fallen to a low of $3.75.

If you're looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get ‘Why Is It Moving' alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Advertisement